September 3, 2010 — In an about face of findings, a new study reports that oral bisphosphonates — widely prescribed for osteoporosis — are associated with an increased risk for esophageal cancer. The ...

Please provide your email address to receive an email when new articles are posted on . Bisphosphonates, a class of drugs developed to prevent the sometimes devastating fractures associated with ...

A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announces that these same drugs -- when used long term -- may ...

Bisphosphonates are prescription drugs that improve bone density. They’re used to treat several conditions associated with bone loss, including osteoporosis, and to reduce the risk of fractures.

August 10, 2010 — Oral bisphosphonates are not significantly associated with esophageal or gastric cancer, according to a large cohort study from the United Kingdom published in the August 11 issue of ...

US regulators have issued a health alert over the possibility of certain osteoporosis treatments causing “severe and sometimes incapacitating” bone, joint and muscle pain in patients suffering from ...

Bisphosphonates are commonly prescribed drugs and their use is increasingly being associated with osteonecrosis of the jaws. Associated factors in the development of osteonecrosis include poor dental ...

Please provide your email address to receive an email when new articles are posted on . The reduced risks for osteoporotic and hip fractures with bisphosphonate therapy outweigh increased risk for ...

Washington, DC, SEPTEMBER 14, 2010– A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announced today that these ...